781 related articles for article (PubMed ID: 36797236)
1. Signaling pathways in rheumatoid arthritis: implications for targeted therapy.
Ding Q; Hu W; Wang R; Yang Q; Zhu M; Li M; Cai J; Rose P; Mao J; Zhu YZ
Signal Transduct Target Ther; 2023 Feb; 8(1):68. PubMed ID: 36797236
[TBL] [Abstract][Full Text] [Related]
2. Novel Targeted Therapies for Rheumatoid Arthritis Based on Intracellular Signalling and Immunometabolic Changes: A Narrative Review.
Rahmati M; Kwesiga MP; Lou J; Tan AL; McDermott MF
Front Biosci (Landmark Ed); 2024 Jan; 29(1):42. PubMed ID: 38287839
[TBL] [Abstract][Full Text] [Related]
3. In Rheumatoid Arthritis, A Review of ncRNAs Related to NF-κB Signaling Pathways.
Wang CX; Cheng HH; Luo M; Jiang JR
Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38424418
[TBL] [Abstract][Full Text] [Related]
4. Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.
Verma MK; Sobha K
Inflamm Res; 2015 Sep; 64(9):647-59. PubMed ID: 26149692
[TBL] [Abstract][Full Text] [Related]
5. Some important inhibitors and mechanisms of rheumatoid arthritis.
Zhou S; Huang G
Chem Biol Drug Des; 2022 Jun; 99(6):930-943. PubMed ID: 34942050
[TBL] [Abstract][Full Text] [Related]
6. New Targets and Strategies for Rheumatoid Arthritis: From Signal Transduction to Epigenetic Aspect.
Zhu M; Ding Q; Lin Z; Fu R; Zhang F; Li Z; Zhang M; Zhu Y
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238636
[TBL] [Abstract][Full Text] [Related]
7. Treatment of rheumatoid arthritis: Unraveling the conundrum.
Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
[TBL] [Abstract][Full Text] [Related]
8. [Progress due to genetic research on rheumatoid arthritis: hype or hope?].
Jacobs JW; Huizinga TW; Bijlsma JW; van der Helm-van Mil AH
Ned Tijdschr Geneeskd; 2009; 153():A206. PubMed ID: 19785838
[TBL] [Abstract][Full Text] [Related]
9. Impact of Adverse Events Associated With Medications in the Treatment and Prevention of Rheumatoid Arthritis.
Costello R; David T; Jani M
Clin Ther; 2019 Jul; 41(7):1376-1396. PubMed ID: 31196653
[TBL] [Abstract][Full Text] [Related]
10. The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery.
Machaj F; Rosik J; Szostak B; Pawlik A
Expert Opin Drug Discov; 2020 Jan; 15(1):85-99. PubMed ID: 31661990
[No Abstract] [Full Text] [Related]
11. Rationalized Insights on Causes of Rheumatoid Arthritis in the Elderly and Women: Special Emphasis on Treatment Strategies.
Srivastava S; Patel S; Singh D; Singh MR
Crit Rev Ther Drug Carrier Syst; 2017; 34(2):97-147. PubMed ID: 28605317
[TBL] [Abstract][Full Text] [Related]
12. Toward Overcoming Treatment Failure in Rheumatoid Arthritis.
Wang Z; Huang J; Xie D; He D; Lu A; Liang C
Front Immunol; 2021; 12():755844. PubMed ID: 35003068
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis Induction of Fibroblast-Like Synoviocytes Is an Important Molecular-Mechanism for Herbal Medicine along with its Active Components in Treating Rheumatoid Arthritis.
Zhang Q; Liu J; Zhang M; Wei S; Li R; Gao Y; Peng W; Wu C
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31795133
[TBL] [Abstract][Full Text] [Related]
14. Genetic susceptibility to rheumatoid arthritis and its implications for novel drug discovery.
Yarwood A; Eyre S; Worthington J
Expert Opin Drug Discov; 2016 Aug; 11(8):805-13. PubMed ID: 27267163
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for rheumatoid arthritis.
Voulgari PV
Expert Opin Emerg Drugs; 2008 Mar; 13(1):175-96. PubMed ID: 18321156
[TBL] [Abstract][Full Text] [Related]
16. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
[TBL] [Abstract][Full Text] [Related]
17. Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology.
Astorri E; Nerviani A; Bombardieri M; Pitzalis C
Curr Pharm Des; 2015; 21(17):2216-24. PubMed ID: 25760296
[TBL] [Abstract][Full Text] [Related]
18. Futuristic Novel Therapeutic Approaches in the Treatment of Rheumatoid Arthritis.
Rai V; Patel N; Mammen SR; Chaudhary SM; Arshad S; Munazzam SW
Cureus; 2023 Nov; 15(11):e49738. PubMed ID: 38161868
[TBL] [Abstract][Full Text] [Related]
19. New pathogenic insights into rheumatoid arthritis.
Jutley G; Raza K; Buckley CD
Curr Opin Rheumatol; 2015 May; 27(3):249-55. PubMed ID: 25775189
[TBL] [Abstract][Full Text] [Related]
20. Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research.
Kim M; Choe YH; Lee SI
Immune Netw; 2022 Feb; 22(1):e8. PubMed ID: 35291656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
